Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(diethylaminoethyl)thioacetoxymutilin
2. 81723 Hfu
3. Dynamutilin
4. Tiamulin
5. Tiamulin Fumarate
6. Tiamulin Fumarate (1:1), (3as-(3aalpha,4beta,5alpha,6alpha,8beta,9alpha,9abeta,10s*))-isomer
7. Tiamulin Hydrochloride
8. Tiamutin
1. Tiamulin Fumarate
2. 55297-96-6
3. Dtxsid901020751
4. Akos015896409
| Molecular Weight | 609.8 g/mol |
|---|---|
| Molecular Formula | C32H51NO8S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 12 |
| Exact Mass | 609.33353876 g/mol |
| Monoisotopic Mass | 609.33353876 g/mol |
| Topological Polar Surface Area | 167 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 889 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tiamulin Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiamulin Fumarate, including repackagers and relabelers. The FDA regulates Tiamulin Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiamulin Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiamulin Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiamulin Fumarate supplier is an individual or a company that provides Tiamulin Fumarate active pharmaceutical ingredient (API) or Tiamulin Fumarate finished formulations upon request. The Tiamulin Fumarate suppliers may include Tiamulin Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Tiamulin Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiamulin Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiamulin Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Tiamulin Fumarate DMFs exist exist since differing nations have different regulations, such as Tiamulin Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiamulin Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Tiamulin Fumarate USDMF includes data on Tiamulin Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiamulin Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiamulin Fumarate suppliers with USDMF on PharmaCompass.
A Tiamulin Fumarate CEP of the European Pharmacopoeia monograph is often referred to as a Tiamulin Fumarate Certificate of Suitability (COS). The purpose of a Tiamulin Fumarate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tiamulin Fumarate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tiamulin Fumarate to their clients by showing that a Tiamulin Fumarate CEP has been issued for it. The manufacturer submits a Tiamulin Fumarate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tiamulin Fumarate CEP holder for the record. Additionally, the data presented in the Tiamulin Fumarate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tiamulin Fumarate DMF.
A Tiamulin Fumarate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tiamulin Fumarate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tiamulin Fumarate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tiamulin Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tiamulin Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tiamulin Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tiamulin Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tiamulin Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tiamulin Fumarate suppliers with NDC on PharmaCompass.
Tiamulin Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiamulin Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiamulin Fumarate GMP manufacturer or Tiamulin Fumarate GMP API supplier for your needs.
A Tiamulin Fumarate CoA (Certificate of Analysis) is a formal document that attests to Tiamulin Fumarate's compliance with Tiamulin Fumarate specifications and serves as a tool for batch-level quality control.
Tiamulin Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Tiamulin Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiamulin Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiamulin Fumarate EP), Tiamulin Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiamulin Fumarate USP).
LOOKING FOR A SUPPLIER?
